Anda belum login :: 27 Nov 2024 17:17 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome
Oleh:
Kuwabara, S.
;
Misawa, S.
;
Kanai, K.
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Neurology (Official Journal of The American Academy of Neurology) vol. 71 no. 21 (Nov. 2008)
,
page 1691-1695.
Topik:
MOTOR CONDUCTION VELOCITIES
;
VASCULAR ENDOTHELIAL GROWTH FACTOR
Ketersediaan
Perpustakaan FK
Nomor Panggil:
N11.K.2008.05
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Background: Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare multisystem disorder associated with plasma cell dyscrasia. There is increasing evidence that high-dose chemotherapy with autologous peripheral blood stem cell transplantation (Auto-PBSCT) is an efficacious treatment. Objective: To elucidate the extent and time course of neurologic improvement after Auto-PBSCT in patients with POEMS syndrome. Methods: Clinical and electrophysiologic findings in nine patients were reviewed. The median follow-up period was 20 months (range, 8 to 49 months). Serum levels of vascular endothelial growth factor (VEGF) were measured by ELISA. Results: Serum VEGF levels rapidly decreased a month after Auto-PBSCT. Within 3 months, neurologic improvement began, and all the patients showed substantial neurologic recovery during the next 3 months. Particularly, three initially chairbound patients regained ability to walk at 6 months. Nerve conduction studies showed significant increases in conduction velocities and amplitudes within 6 months of treatment. At the end of follow-up periods, neuropathy was still improving, and no patients had recurrence of symptoms. Conclusion: Autologous peripheral blood stem cell transplantation results in obvious neurologic improvement within 6 months, presumably by extensive axonal regeneration and remyelination. This therapy could be considered as a first line treatment for patients with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome with younger onset even if they are tetraplegic.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.046875 second(s)